Clinical trial · Interventional
Laparoscopic IIeocecus-Sparing Right Hemicolectomy for Cancer of the Hepatic Flexure and Proximal Transverse Colon
An Open, Single-arm, Single Center, Clinical Trial to Investigate the Feasibility and Safety of Laparoscopic Ileocecus-sparing Right Hemicolectomy for Cancer of the Hepatic Flexure and Proximal Transverse Colon
NCT04479111CI-TRIAL-00063793LISHcompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To investigate whether laparoscopic ileocecus-sparing right hemicolectomy is feasible and oncologically safe
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hepatic Flexure Colon Cancer | — | UNRESOLVED | — |
| Proximal Transverse Colon Cancer | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| laparoscopic ileocecus-sparing right hemicolectomy | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- LISRH group
- description
- Following the principle of complete mesocolic excision(CME), Ileocecus-Sparing Right colectomy refers to the resection of the most portion of the ascending colon, hepatic flexure and mid to distal transverse colon. The extent of lymph node dissection and length of distal resection margin are similar to conventional right hemicolectomy. The length of proximal resection margin varies.
- interventionNames
- Procedure: laparoscopic ileocecus-sparing right hemicolectomy
Primary outcomes (2)
- measure
- Postoperative complications
- timeFrame
- up to 90 days after surgery
- description
- Postoperative complications used to calculate the Comprehensive Complication Index (CCI) will be recorded
- measure
- 1-year local recurrence
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: 1. Patients suitable for curative surgery 18-75years old 2. ASA grade I-III 3. Qualitative diagnosis: a pathological diagnosis of adenocarcinoma; 4. Localization diagnosis: the tumor located at hepatic flexure and proximal transverse colon(proximal to the right branch of middle colic artery); 5. Enhanced CT scan of chest, abdominal and pelvic cavity: assessment of tumor stage is T1-T4N0 or TanyN+; there is no distant metastasis. 6. Intraoperative measurement: the distance between colic branch of ileocolic artery and proximal edge of the tumor should be longer than 5cm. 7. Informed consent Exclusion Criteria: 1. Simultaneous or metachronous multiple primary colorectal cancer; 2. History of familial adenomatous polyposis, ulcerative colitis or Crohn's disease. 3. Preoperative imaging examination results show: fused lymph node at the root of ileocolic artery. 4. Distant metastasis. 5. History of any other malignant tumor in recent 5 years. 6. Patients need emergency operation. 7. Not suitable for laparoscopic surgery (i.e., extensive adhesion caused by abdominal surgery, not suitable for artificial pneumoperitoneum, etc). 8. Informed consent refusal
References
Publications (0)
Data not yet available
No reference posted for this study.